Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Fatigue in COPD and the impact of respiratory symptoms and heart disease: a population-based study
Luleå tekniska universitet, Institutionen för hälsovetenskap.ORCID iD: 0000-0001-6622-3838
WorldWide Epidemiology, GlaxoSmithKline R&D.
Luleå tekniska universitet, Omvårdnad.
OLIN studies, Sunderby Hospital.
2013 (English)In: COPD: Journal of Chronic Obstructive Pulmonary Disease, ISSN 1541-2555, E-ISSN 1541-2563, Vol. 10, no 2, 125-132 p.Article in journal (Refereed) Published
Abstract [en]

Background: Fatigue is reported in COPD and in heart disease; however, there are hardly any population based data on the relationship between these conditions. Aim: To describe fatigue in relation to COPD by disease severity and to evaluate the impact of respiratory symptoms and heart disease. Methods: Data were collected in 2007 from the OLIN COPD study; 564 subjects with COPD (FEV1/FVC < 0.70) and a distribution of disease severity representative for the general population, and 786 subjects without COPD. The Functional Assessment of Chronic Illness Therapy (FACIT)—Fatigue scale was used to assess fatigue (0–52); lower scores represent worse fatigue. Results: Median FACIT-F score was 44.0 in COPD defined by merely spirometric criteria and 42.0 in COPD also reporting respiratory symptoms, significantly lower compared to 46.0 in non-COPD (p = 0.006 and p < 0.001), and decreased by disease severity. The score was lower in COPD stage ≥ II and in COPD with respiratory symptoms already from stage I when compared to non-COPD. Subjects with heart disease reported lower scores than those without heart disease in COPD by all stages and in non-COPD. COPD with respiratory symptoms stage ≥II remained a significant risk factor for clinically significant fatigue also when adjusted for gender, age, heart disease and smoking habits (stage II OR 1.65, CI 1.17-2.31 and stage III-IV OR 2.66, CI 1.11-6.36). Conclusion: Fatigue is common in COPD, and is affected by respiratory symptoms and concomitant heart disease. In COPD with respiratory symptoms stage ≥ II, there is an increased risk for clinically significant fatigue.Read More: http://informahealthcare.com/doi/abs/10.3109/15412555.2012.728642?ai=1rzjm&ui=oxk4&af=T&

Place, publisher, year, edition, pages
2013. Vol. 10, no 2, 125-132 p.
National Category
Nursing
Research subject
Nursing
Identifiers
URN: urn:nbn:se:bth-14337DOI: 10.3109/15412555.2012.728642Local ID: ad4607b8-4222-4ddb-95e0-fe819040d90eOAI: oai:DiVA.org:bth-14337DiVA: diva2:1098037
Note

Validerad; 2013; 20120912 (andbra)

Available from: 2016-09-29 Created: 2017-05-23

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Stridsman, CarolineSkär, Lisa
In the same journal
COPD: Journal of Chronic Obstructive Pulmonary Disease
Nursing

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf